Hallosen, 0,5 mg/ml suukaudne lahus vasikatele
Hallosen, 0,5 mg/ml suukaudne lahus vasikatele
Authorised
- Halofuginone lactate
Product identification
Medicine name:
Hallosen, 0,5 mg/ml suukaudne lahus vasikatele
Active substance:
- Halofuginone lactate
Target species:
-
Cattle (newborn calf)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Halofuginone lactate0.60/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Cattle (newborn calf)
-
Meat and offal13day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP51BX01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Interchemie Werken De Adelaar Eesti AS
Marketing authorisation date:
Manufacturing sites for batch release:
- Interchemie Werken De Adelaar Eesti AS
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1266926
Date of authorisation status change:
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 31/08/2026